{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T13:26:38Z","timestamp":1779888398352,"version":"3.53.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,10,5]],"date-time":"2016-10-05T00:00:00Z","timestamp":1475625600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"The National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81173127"],"award-info":[{"award-number":["81173127"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"The National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81273581"],"award-info":[{"award-number":["81273581"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1007\/s00228-016-2137-7","type":"journal-article","created":{"date-parts":[[2016,10,5]],"date-time":"2016-10-05T01:07:31Z","timestamp":1475629651000},"page":"29-37","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Hepatic expression of transcription factors affecting developmental regulation of UGT1A1 in the Han Chinese population"],"prefix":"10.1007","volume":"73","author":[{"given":"Ya-li","family":"Nie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang-feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-guang","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-zheng","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-rong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan-cheng","family":"Kan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,5]]},"reference":[{"issue":"2","key":"2137_CR1","doi-asserted-by":"crossref","first-page":"103","DOI":"10.5507\/bp.2010.017","volume":"154","author":"P Jancova","year":"2010","unstructured":"Jancova P, Anzenbacher P, Anzenbacherova E (2010) Phase II drug metabolizing enzymes. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 154(2):103\u2013116","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"issue":"3","key":"2137_CR2","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/sj.tpj.6500171","volume":"3","author":"C Guillemette","year":"2003","unstructured":"Guillemette C (2003) Pharmacogenomics of human UDP-glucuronosyltransferase enzymes. Pharmacogenomics J 3(3):136\u2013158","journal-title":"Pharmacogenomics J"},{"key":"2137_CR3","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1089\/dna.1991.10.487","volume":"10","author":"B Burchell","year":"1991","unstructured":"Burchell B, Nebert DW, Nelson DR, Bock KW, Iyanagi T, Jansen PL, Lancet D, Mulder GJ, Chowdhury JR, Siest G et al (1991) The UDP glucuronosyltransferase gene superfamily: suggested nomenclature based on evolutionary divergence. DNA Cell Biol 10:487\u2013494","journal-title":"DNA Cell Biol"},{"issue":"27","key":"2137_CR4","doi-asserted-by":"crossref","first-page":"17960","DOI":"10.1016\/S0021-9258(17)32403-1","volume":"269","author":"PJ Bosma","year":"1994","unstructured":"Bosma PJ, Seppen J, Goldhoorn B, Bakker C, Oude Elferink RP, Chowdhury JR, Chowdhury NR, Jansen PL (1994) Bilirubin UDP-glucuronosyltransferase 1 is the only relevant bilirubin glucuronidating isoform in man. J Biol Chem 269(27):17960\u201317964","journal-title":"J Biol Chem"},{"issue":"2","key":"2137_CR5","first-page":"169","volume":"10","author":"JF Crigler Jr","year":"1952","unstructured":"Crigler JF Jr, NAJJAR VA (1952) Congenital familial nonhemolytic jaundice with kernicterus. Pediatrics 10(2):169\u2013180","journal-title":"Pediatrics"},{"issue":"4","key":"2137_CR6","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1203\/00006450-200210000-00022","volume":"52","author":"CS Huang","year":"2002","unstructured":"Huang CS, Chang PF, Huang MJ, Chen ES, Hung KL, Tsou KI (2002) Relationship between bilirubin UDP-glucuronosyl transferase 1A1 gene and neonatal hyperbilirubinemia. Pediatr Res 52(4):601\u2013605","journal-title":"Pediatr Res"},{"issue":"3","key":"2137_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0151375","volume":"11","author":"AA Emokpae","year":"2016","unstructured":"Emokpae AA, Mabogunje CA, Imam ZO, Olusanya BO (2016) Heliotherapy for Neonatal Hyperbilirubinemia in Southwest, Nigeria: a baseline pre-intervention study. PLoS One 11(3), e0151375. doi: 10.1371\/journal.pone.0151375 , eCollection 2016","journal-title":"PLoS One"},{"key":"2137_CR8","doi-asserted-by":"publisher","first-page":"6343","DOI":"10.1038\/srep06343","volume":"4","author":"N Aoshima","year":"2014","unstructured":"Aoshima N, Fujie Y, Itoh T, Tukey RH, Fujiwara R (2014) Glucose induces intestinal human UDP-glucuronosyltransferase (UGT) 1A1 to prevent neonatal hyperbilirubinemia. Sci Rep 4:6343. doi: 10.1038\/srep06343","journal-title":"Sci Rep"},{"issue":"1","key":"2137_CR9","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1053\/j.gastro.2011.09.045","volume":"142","author":"R Fujiwara","year":"2012","unstructured":"Fujiwara R, Chen S, Karin M, Tukey RH (2012) Reduced expression of UGT1A1 in intestines of humanized UGT1 mice via inactivation of NF-kB leads to hyperbilirubinemia. Gastroenterology 142(1):109\u2013118","journal-title":"Gastroenterology"},{"issue":"1","key":"2137_CR10","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.taap.2015.08.018","volume":"289","author":"R Fujiwara","year":"2015","unstructured":"Fujiwara R, Maruo Y, Chen S, Tukey RH (2015) Role of extrahepatic UDP-glucuronosyltransferase 1A1: advances in understanding breast milk-induced neonatal hyperbilirubinemia. Toxicol Appl Pharmacol 289(1):124\u2013132","journal-title":"Toxicol Appl Pharmacol"},{"issue":"7","key":"2137_CR11","volume":"10","author":"H Yang","year":"2015","unstructured":"Yang H, Wang Q, Zheng L, Lin M, Zheng XB, Lin F, Yang LY (2015) Multiple genetic modifiers of bilirubin metabolism involvement in significant neonatal hyperbilirubinemia in patients of Chinese descent. PLoS One 10(7), e0132034","journal-title":"PLoS One"},{"key":"2137_CR12","first-page":"3677","volume":"9","author":"C Yang","year":"2015","unstructured":"Yang C, Liu Y, Xi WQ, Zhou CF, Jiang JL, Ma T, Ye ZB, Zhang J, Zhu ZG (2015) Relationship between UGT1A1*6\/*28 polymorphisms and severe toxicities in Chinese patients with pancreatic orbiliary tract cancer treated with irinotecan-containing regimens. Drug Des Devel Ther 9:3677\u20133683","journal-title":"Drug Des Devel Ther"},{"issue":"28","key":"2137_CR13","doi-asserted-by":"crossref","first-page":"4534","DOI":"10.1200\/JCO.2006.07.3031","volume":"24","author":"PJ O\u2019Dwyer","year":"2006","unstructured":"O\u2019Dwyer PJ, Catalano RB (2006) Uridine diphosphate glucuronosyltransferase (UGT) 1A1 and irinotecan: practical pharmacogenomics arrives in cancer therapy. J Clin Oncol 24(28):4534\u20134538","journal-title":"J Clin Oncol"},{"issue":"42","key":"2137_CR14","doi-asserted-by":"crossref","first-page":"6621","DOI":"10.1038\/sj.onc.1206958","volume":"22","author":"AA Desai","year":"2003","unstructured":"Desai AA, Innocenti F, Ratain MJ (2003) Pharmacogenomics: road to anticancer therapeutics nirvana? Oncogene 22(42):6621\u20136628","journal-title":"Oncogene"},{"issue":"16","key":"2137_CR15","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1200\/JCO.2008.20.6300","volume":"27","author":"F Innocenti","year":"2009","unstructured":"Innocenti F, Kroetz DL, Schuetz E, Dolan ME, Ram\u00edrez J, Relling M, Chen P, Das S, Rosner GL, Ratain MJ (2009) Comprehensive pharmacogenetic analysis of irinotecan neutropenia and pharmacokinetics. J Clin Oncol 27(16):2604\u20132614","journal-title":"J Clin Oncol"},{"issue":"2","key":"2137_CR16","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1124\/jpet.300.2.361","volume":"300","author":"DG McCarver","year":"2002","unstructured":"McCarver DG, Hines RN (2002) The ontogeny of human drug-metabolizing enzymes: phase II conjugation enzymes and regulatory mechanisms. J Pharmacol Exp Ther 300(2):361\u2013366","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"2137_CR17","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2165\/00003088-199937060-00004","volume":"37","author":"SN Wildt de","year":"1999","unstructured":"de Wildt SN, Kearns GL, Leeder JS, van den Anker JN (1999) Cytochrome P450 3A: ontogeny and drug disposition. Clin Pharmacokinet 37(6):485\u2013505","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"2137_CR18","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1042\/bj1960257","volume":"196","author":"N Kawade","year":"1981","unstructured":"Kawade N, Onishi S (1981) The prenatal and postnatal development of UDP-glucuronyltransferase activity towards bilirubin and the effect of premature birth on this activity in the human liver. Biochem J 196(1):257\u2013260","journal-title":"Biochem J"},{"issue":"5","key":"2137_CR19","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1124\/dmd.110.037192","volume":"39","author":"SJ Miyagi","year":"2011","unstructured":"Miyagi SJ, Collier AC (2011) The development of UDP-glucuronosyltransferases 1A1 and 1A6 in the pediatric liver. Drug Metab Dispos 39(5):912\u2013919","journal-title":"Drug Metab Dispos"},{"issue":"2\u20134","key":"2137_CR20","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000457587","volume":"13","author":"B Burchell","year":"1989","unstructured":"Burchell B, Coughtrie M, Jackson M, Harding D, Fournel-Gigleux S, Leakey J, Hume R (1989) Development of human liver UDP-glucuronosyltransferases. Dev Pharmacol Ther 13(2\u20134):70\u201377","journal-title":"Dev Pharmacol Ther"},{"issue":"4","key":"2137_CR21","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1124\/dmd.112.050211","volume":"41","author":"H Lu","year":"2013","unstructured":"Lu H, Gunewardena S, Cui JY, Yoo B, Zhong XB, Klaassen CD (2013) RNA-sequencing quantification of hepatic ontogeny and tissue distribution of mRNAs of phase II enzymes inmice. Drug Metab Dispos 41(4):844\u2013857","journal-title":"Drug Metab Dispos"},{"issue":"6","key":"2137_CR22","first-page":"761","volume":"97","author":"JM Sutherland","year":"1959","unstructured":"Sutherland JM (1959) Fatal cardiovascular collapse of infants receiving large amounts of chloramphenicol. AMA J Dis Child 97(6):761\u2013767","journal-title":"AMA J Dis Child"},{"key":"2137_CR23","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1056\/NEJM196004212621601","volume":"262","author":"CF Weiss","year":"1960","unstructured":"Weiss CF, Glasko AJ, Weston JK (1960) Chloramphenicol in the newborn infant. A physiologic explanation of its toxicity when given in excessive doses. N Engl J Med 262:787\u2013794","journal-title":"N Engl J Med"},{"issue":"6","key":"2137_CR24","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.bcp.2010.04.034","volume":"80","author":"KW Bock","year":"2010","unstructured":"Bock KW (2010) Functions and transcriptional regulation of adult human hepatic UDP-glucuronosyl-transferases (UGTs): mechanisms responsible for interindividual variation of UGT levels. Biochem Pharmacol 80(6):771\u2013777","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"2137_CR25","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/bcpt.12392","volume":"117","author":"S Betts","year":"2015","unstructured":"Betts S, Bj\u00f6rkhem-Bergman L, Rane A, Ekstr\u00f6m L (2015) Expression of CYP3A4 and CYP3A7 in human foetal tissues and its correlation with nuclear receptors. Basic Clin Pharmacol Toxicol 117(4):261\u2013266","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"1","key":"2137_CR26","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.bcp.2014.10.010","volume":"93","author":"J Li","year":"2015","unstructured":"Li J, Wan Y, Na S, Liu X, Dong G, Yang Z, Yang J, Yue J (2015) Sex-dependent regulation of hepatic CYP3A by growth hormone: roles of HNF6, C\/EBP\u03b1, and RXR\u03b1. Biochem Pharmacol 93(1):92\u2013103","journal-title":"Biochem Pharmacol"},{"issue":"20","key":"2137_CR27","doi-asserted-by":"crossref","first-page":"5558","DOI":"10.1093\/hmg\/ddu268","volume":"23","author":"W Liu","year":"2014","unstructured":"Liu W, Ram\u00edrez J, Gamazon ER, Mirkov S, Chen P, Wu K, Sun C, Cox NJ, Cook E Jr, Das S, Ratain MJ (2014) Genetic factors affecting gene transcription and catalytic activity of UDP-glucuronosyltransferases in human liver. Hum Mol Genet 23(20):5558\u20135569","journal-title":"Hum Mol Genet"},{"issue":"9","key":"2137_CR28","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1124\/dmd.109.027409","volume":"37","author":"Y Li","year":"2009","unstructured":"Li Y, Buckley D, Wang S, Klaassen CD, Zhong XB (2009) Genetic polymorphisms in the TATA box and upstream phenobarbital-responsive enhancer module of the UGT1A1 promoter have combined effects on UDP-glucuronosyltransferase 1A1 transcription mediated by constitutive androstane receptor, pregnane X receptor, or glucocorticoid receptor in human liver. Drug Metab Dispos 37(9):1978\u201386","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"2137_CR29","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1042\/BJ20121055","volume":"449","author":"TY Shiu","year":"2013","unstructured":"Shiu TY, Huang TY, Huang SM, Shih YL, Chu HC, Chang WK, Hsieh TY (2013) Nuclear factor kB down-regulates human UDP-glucuronosyltransferase 1A1: a novel mechanism involved in inflammation-associated hyperbilirubinaemia. Biochem J 449(3):761\u2013770","journal-title":"Biochem J"},{"issue":"10","key":"2137_CR30","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1124\/dmd.113.051201","volume":"41","author":"S Oda","year":"2013","unstructured":"Oda S, Fukami T, Yokoi T, Nakajima M (2013) Epigenetic regulation is a crucial factor in the repression of UGT1A1 expression in the human kidney. Drug Metab Dispos 41(10):1738\u20131743","journal-title":"Drug Metab Dispos"},{"key":"2137_CR31","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1471-2199-11-9","volume":"11","author":"AS B\u00e9langer","year":"2010","unstructured":"B\u00e9langer AS, Tojcic J, Harvey M, Guillemette C (2010) Regulation of UGT1A1 and HNF1 transcription factor gene expression by DNA methylation in colon cancer cells. BMC Mol Biol 11:9. doi: 10.1186\/1471-2199-11-9","journal-title":"BMC Mol Biol"},{"issue":"2","key":"2137_CR32","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/sj.tpj.6500454","volume":"8","author":"J Ram\u00edrez","year":"2008","unstructured":"Ram\u00edrez J, Mirkov S, Zhang W, Chen P, Das S, Liu W, Ratain MJ, Innocenti F (2008) Hepatocyte nuclear factor-1 alpha is associated with UGT1A1, UGT1A9 and UGT2B7 mRNA expression in human liver. Pharmacogenomics J 8(2):152\u2013161","journal-title":"Pharmacogenomics J"},{"key":"2137_CR33","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) Method. Methods 25:402\u2013408","journal-title":"Methods"},{"issue":"1","key":"2137_CR34","doi-asserted-by":"crossref","first-page":"20d","DOI":"10.1083\/jcb.50.1.20d","volume":"50","author":"C Duve De","year":"1971","unstructured":"De Duve C (1971) Tissue fractionation-past and present. J Cell Biol 50(1):20d\u201355d","journal-title":"J Cell Biol"},{"issue":"11","key":"2137_CR35","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1124\/dmd.110.033829","volume":"38","author":"J Zhou","year":"2010","unstructured":"Zhou J, Tracy TS, Remmel RP (2010) Bilirubin glucuronidation revisited: proper assay conditions to estimate enzyme kinetics with recombinant UGT1A1. Drug Metab Dispos 38(11):1907\u20131911","journal-title":"Drug Metab Dispos"},{"key":"2137_CR36","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jpba.2014.01.025","volume":"92","author":"G Ma","year":"2014","unstructured":"Ma G, Lin J, Cai WM, Tan B, Xiang X, Zhang Y, Zhang P (2014) Simultaneous determination of bilirubin and its glucuronides in liver microsomes and recombinant UGT1A1 enzyme incubation systems by HPLC method and its application to bilirubin glucuronidation studies. J Pharm Biomed Anal 92:149\u2013159","journal-title":"J Pharm Biomed Anal"},{"issue":"2","key":"2137_CR37","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/gut.50.2.259","volume":"50","author":"CP Strassburg","year":"2002","unstructured":"Strassburg CP, Strassburg A, Kneip S, Barut A, Tukey RH, Rodeck B, Manns MP (2002) Developmental aspects of human hepatic drug glucuronidation in young children and adults. Gut 50(2):259\u2013265","journal-title":"Gut"},{"issue":"10","key":"2137_CR38","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1096\/fasebj.10.10.8751713","volume":"10","author":"FJ Gonzalez","year":"1996","unstructured":"Gonzalez FJ, Lee YH (1996) Constitutive expression of hepatic cytochrome P450 genes. FASEB J 10(10):1112\u20131117","journal-title":"FASEB J"},{"issue":"6","key":"2137_CR39","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1124\/dmd.30.6.613","volume":"30","author":"K Toide","year":"2002","unstructured":"Toide K, Takahashi Y, Yamazaki H, Terauchi Y, Fujii T, Parkinson A, Kamataki T (2002) Hepatocyte nuclear factor-1 alpha is a causal factor responsible for interindividual differences in the expression of UDP-glucuronosyltransferase 2B7 mRNA in human livers. Drug Metab Dispos 30(6):613\u2013615","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"2137_CR40","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1124\/dmd.105.005967","volume":"34","author":"CA Vyhlidal","year":"2006","unstructured":"Vyhlidal CA, Gaedigk R, Leeder JS (2006) Nuclear receptor expression in fetal and pediatric liver: correlation with CYP3A expression. Drug Metab Dispos 34(1):131\u2013137","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"2137_CR41","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.bcp.2011.03.011","volume":"82","author":"KW Bock","year":"2011","unstructured":"Bock KW (2011) From differential induction of UDP-glucuronosyltransferases in rat liver to characterization of responsible ligand-activated transcription factors, and their multilevel crosstalk in humans. Biochem Pharmacol 82(1):9\u201316","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"2137_CR42","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3109\/03602530903208983","volume":"42","author":"Z Ou","year":"2010","unstructured":"Ou Z, Huang M, Zhao L, Xie W (2010) Use of transgenic mice in UDP-glucuronosyltransferase (UGT) studies. Drug Metab Rev 42(1):123\u2013131","journal-title":"Drug Metab Rev"},{"issue":"7","key":"2137_CR43","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1124\/dmd.112.045112","volume":"40","author":"LM Aleksunes","year":"2010","unstructured":"Aleksunes LM, Klaassen CD (2010) Coordinated regulation of hepatic phase I and II drug-metabolizing genes and transporters using AhR-, CAR-, PXR-, PPAR\u03b1-, and Nrf2-null mice. Drug Metab Dispos 40(7):1366\u20131379","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"2137_CR44","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/BF02977789","volume":"28","author":"C Xu","year":"2005","unstructured":"Xu C, Li CY, Kong AN (2005) Induction of phase I, II and III drug metabolism\/transport by xenobiotics. Arch Pharm Res 28(3):249\u2013268","journal-title":"Arch Pharm Res"},{"issue":"4","key":"2137_CR45","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3109\/03602532.2014.973037","volume":"46","author":"DG Hu","year":"2014","unstructured":"Hu DG, Meech R, McKinnon RA, Mackenzie PI (2014) Transcriptional regulation of human UDP-glucuronosyltransferase genes. Drug Metab Rev 46(4):421\u2013458","journal-title":"Drug Metab Rev"},{"issue":"3","key":"2137_CR46","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1124\/jpet.113.210658","volume":"348","author":"DF Dluzen","year":"2014","unstructured":"Dluzen DF, Sun D, Salzberg AC, Jones N, Bushey RT, Robertson GP, Lazarus P (2014) Regulation of UDP-glucuronosyltransferase 1A1 expression and activity by microRNA 491-3p. J Pharmacol Exp Ther 348(3):465\u2013477","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"2137_CR47","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3109\/03602530903210682","volume":"42","author":"C Guillemette","year":"2010","unstructured":"Guillemette C, L\u00e9vesque E, Harvey M, Bellemare J, Menard V (2010) UGT genomic diversity: beyond gene duplication. Drug Metab Rev 42(1):24\u201344","journal-title":"Drug Metab Rev"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-016-2137-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-016-2137-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-016-2137-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T19:27:51Z","timestamp":1718825271000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-016-2137-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,5]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["2137"],"URL":"https:\/\/doi.org\/10.1007\/s00228-016-2137-7","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,5]]}}}